Elite Pharma Inc (ELTP)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 03/31
| 03-2023 | 12-2022 | 09-2022 | 06-2022 | 03-2022 | |
| Sales | 8,646 | 9,250 | 8,586 | 7,673 | 7,672 |
| Cost of Goods | 4,794 | 4,331 | 4,761 | 3,675 | 4,216 |
| Gross Profit | 3,853 | 4,919 | 3,824 | 3,998 | 3,456 |
| Operating Expenses | 5,033 | 3,291 | 3,505 | 3,650 | 2,820 |
| Operating Income | -387 | 1,959 | 1,081 | 1,023 | 852 |
| Interest Expense | 331 | 323 | 243 | 217 | 65 |
| Other Income | -139 | 1,373 | 688 | -500 | -98 |
| Pre-tax Income | -856 | 3,009 | 1,527 | 306 | 688 |
| Income Tax | 373 | 39 | 12 | N/A | -885 |
| Net Income Continuous | -1,229 | 2,970 | 1,515 | 306 | 2,431 |
| Net Income | $-1,229 | $2,970 | $1,515 | $306 | $2,431 |
| EBITDA(a) | $-37 | $2,282 | $1,406 | $1,370 | $1,203 |